Security key
12233L107
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)
CUSIP: 12233L107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
- Shares outstanding
- 9,036,176
- Total 13F shares
- 22,097
- Share change
- -20,627,587
- Total reported value
- $136,094
- Price per share
- $3.62
- Number of holders
- 2
- Value change
- -$16,092,890
- Number of sells
- 19
Report period
Q2 2024
Institutions
2
Top holders
2
BNR full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Burning Rock Biotech Ltd SEC filings
Burning Rock Biotech Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12233L107
Recent filing periods:
Top shareholders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP |
13F
|
Company |
107%
|
9,640,914
|
$7,019,549 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
45%
|
4,026,892
|
$2,931,981 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
31%
|
2,808,981
|
$2,048,309 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
19%
|
1,737,208
|
$1,266,772 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
6.5%
|
591,428
|
$430,619 | — | 31 Mar 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
6.5%
|
591,428
|
$419,914 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.8%
|
342,700
|
$250,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
3.2%
|
292,868
|
$213,208 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
223,881
|
$163,008 | — | 31 Mar 2024 | |
| HSG Holding Ltd |
13F
|
Company |
2.3%
|
212,121
|
$182,212 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.74%
|
66,962
|
$48,829 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.54%
|
49,020
|
$35,745 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
25,600
|
$18,667 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
19,084
|
$13,916 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
12,558
|
$9,157 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
5,805
|
$4,230 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
1,201
|
$876 | — | 31 Mar 2024 | |
| Neil Nanpeng Shen |
13F
|
Individual |
0.01%
|
885
|
$761 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
83
|
$60 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
65
|
$47 | — | 31 Mar 2024 |
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2024
As of 30 Jun 2024,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,097 shares.
The largest 2 holders included
HSG Holding Ltd and SHEN NEIL NANPENG.
This page lists
2
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
20
Q2 2024 holders
2
Holder diff
-18
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.